Pharmacology MSN 571 practice questions
with correct answers
A |patient |diagnosed |with |chronic |pain |calls |to |request |an |oxycodone |(Oxycontin) |refill. |Which |action |
should |the |prescriber |take |initially? |- |VERIFIED |ANSWER-Arrange |to |schedule |an |appointment |with |
the |patient.
A |metered-dose |albuterol |inhaler |is |prescribed |for |asthma |management. |The |patient |reports |feeling |
jittery |sometimes |when |taking |the |medication, |and |does |not |feel |that |the |medication |is |always |
effective. |Which |action |will |the |provider |take |to |best |minimize |patient |risks |and |maximize |medication
|effectiveness? |- |VERIFIED |ANSWER-Auscultate |the |patient's |lung |sounds |and |obtain |other |relevant |
vital |signs.
A |patient |is |prescribed |metronidazole |for |bacterial |vaginosis. |Which |patient |history |finding |would |be |
most |concerning |to |the |provider? |- |VERIFIED |ANSWER-The |patient |drinks |two |glasses |of |wine |every |
night.
The |provider |prepares |a |patient |with |newly |diagnosed |type |1 |diabetes |for |hospital |discharge. |Which |
action |by |the |provider |will |best |support |the |patient's |ability |to |effectively |manage |medication |
therapy? |- |VERIFIED |ANSWER-Asking |the |patient |to |demonstrate |how |to |measure |and |administer |
insulin
A |patient |reports |that |a |medication |prescribed |for |recurrent |migraine |headaches |is |not |working. |
Which |action |is |the |prescriber's |priority |when |addressing |the |patient's |concern? |- |VERIFIED |ANSWER-
Ask |the |patient |about |the |number |and |frequency |of |tablets |taken.
The |drug |manual |states |that |older |adult |patients |are |at |increased |risk |for |hepatotoxicity. |Which |
action |is |most |important |when |prescribing |this |medication |to |an |80-year-old |patient? |- |VERIFIED |
ANSWER-Obtaining |baseline |liver |function |studies
A |patient |with |bipolar |disorder |is |prescribed |daily |lithium. |Which |action |is |most |important |for |the |
provider |to |take |in |order |to |determine |if |the |therapeutic |level |is |maintained? |- |VERIFIED |ANSWER-
Order |periodic |laboratory |testing.
Which |factor |best |supports |an |increase |for |full |prescriptive |authority |for |both |advanced |practice |
registered |nurses |(APRNs) |and |physician |assistants |(PAs)? |- |VERIFIED |ANSWER-More |patients |will |have
|access |to |health |care.
A |pediatric |patient |prescribed |ampicillin |for |streptococcal |pharyngitis |reports |new |onset |of |a |pruritic, |
dull |red, |maculopapular |rash |on |the |chest |and |neck. |Which |action |is |most |important |for |the |provider |
to |take |to |minimize |this |patient's |risk |for |injury? |- |VERIFIED |ANSWER-Discontinue |the |ampicillin.
, Which |prescriber |action |will |have |the |greatest |impact |on |the |patient's |commitment |to |adherence |to |
any |type |of |medication |therapy? |- |VERIFIED |ANSWER-Providing |medication |education |that |the |patient
|can |easily |understand
Which |patient |statement |suggests |to |the |provider |that |the |patient's |nonadherence |with |their |
medication |plan |is |related |to |dissatisfaction |with |the |therapy? |- |VERIFIED |ANSWER-"I've |been |taking |
this |medication |for |well |over |a |week |and |I |lost |only |a |half |a |pound."
How |can |the |prescriber's |regular |collaboration |with |a |pharmacist |improve |positive |outcomes |for |
patients? |- |VERIFIED |ANSWER-Pharmacists |have |additional |information |on |drug |interactions. |The |
pharmacist |can |suggest |adequate |medication |dosing. |Pharmacists |have |firsthand |knowledge |of |the |
facility |formulary.
Which |statements |made |by |the |prescriber |demonstrate |an |understanding |of |effective |medication |
education? |- |VERIFIED |ANSWER-"This |medication |needs |to |be |stored |in |the |refrigerator. |"Take |3 |
tablets |daily: |1 |with |breakfast, |1 |with |lunch, |and |one |with |dinner." |"You |need |to |take |the |medication |
as |we |discussed |until |all |the |tablets |are |gone." |"Call |the |office |immediately |if |you |begin |experiencing |
any |itching, |headache, |or |difficulty |breathing."
The |patient |who |has |been |prescribed |lithium |for |a |diagnosis |of |bipolar |disorder |asks |why |blood |tests |
are |required |on |a |regular |basis. |Which |provider |responses |demonstrate |an |understanding |of |why |the |
patient |requires |a |variety |of |laboratory |tests? |- |VERIFIED |ANSWER-"We |need |to |monitor |how |your |
thyroid |is |functioning." |"We |need |to |monitor |kidney |function |while |you |are |on |this |drug. |This |
medication |can |cause |you |to |lose |sodium, |so |we |need |to |measure |sodium |levels."
When |prescribing |lovastatin, |what |will |a |provider |advise |to |decrease |the |risk |of |developing |muscle |
toxicity? |- |VERIFIED |ANSWER-Substitute |grapefruit |juice |with |orange |juice
When |prescribing |drugs |with |a |narrow |therapeutic |index, |what |intervention |does |the |provider |take |to
|decrease |risk |to |the |patient? |- |VERIFIED |ANSWER-Monitor |the |patient's |plasma |drug |levels |at |regular |
intervals.
A |patient |reports |that |a |medication |no |longer |effectively |alleviates |symptoms. |What |process |informs |
the |provider's |response |to |the |patient's |concerns? |- |VERIFIED |ANSWER-Desensitization |of |receptor |
sites |results |from |continual |exposure |to |the |drug.
A |patient |reports |that |Brand |X |tablets |work |faster |than |Brand |Y |tablets |of |the |same |amount |of |the |
same |drug. |Which |statement |informs |the |prescriber's |response |when |explaining |this |phenomenon |to |
the |patient? |- |VERIFIED |ANSWER-Inactive |ingredients |used |in |composition |can |result |in |differing |rates |
of |dissolution, |which |can |alter |the |drug's |onset |of |action.
A |patient |receiving |intravenous |gentamicin |has |a |toxic |serum |drug |level. |The |prescriber |confirms |that |
the |dosing |is |correct. |Which |possible |cause |of |this |situation |will |the |provider |explore? |- |VERIFIED |
ANSWER-Whether |patient |is |taking |a |medication |that |binds |to |serum |albumin.
A |patient |takes |a |drug |that |is |metabolized |by |CYP3A4 |isoenzymes. |If |a |CYP3A4 |inducing |drug |is |
prescribed, |what |drug |adjustment |may |be |necessary |to |maintain |a |therapeutic |level |of |CYP3A4 |
substrate? |- |VERIFIED |ANSWER-Increase |dosage |of |the |CYP3A4 |substrate
with correct answers
A |patient |diagnosed |with |chronic |pain |calls |to |request |an |oxycodone |(Oxycontin) |refill. |Which |action |
should |the |prescriber |take |initially? |- |VERIFIED |ANSWER-Arrange |to |schedule |an |appointment |with |
the |patient.
A |metered-dose |albuterol |inhaler |is |prescribed |for |asthma |management. |The |patient |reports |feeling |
jittery |sometimes |when |taking |the |medication, |and |does |not |feel |that |the |medication |is |always |
effective. |Which |action |will |the |provider |take |to |best |minimize |patient |risks |and |maximize |medication
|effectiveness? |- |VERIFIED |ANSWER-Auscultate |the |patient's |lung |sounds |and |obtain |other |relevant |
vital |signs.
A |patient |is |prescribed |metronidazole |for |bacterial |vaginosis. |Which |patient |history |finding |would |be |
most |concerning |to |the |provider? |- |VERIFIED |ANSWER-The |patient |drinks |two |glasses |of |wine |every |
night.
The |provider |prepares |a |patient |with |newly |diagnosed |type |1 |diabetes |for |hospital |discharge. |Which |
action |by |the |provider |will |best |support |the |patient's |ability |to |effectively |manage |medication |
therapy? |- |VERIFIED |ANSWER-Asking |the |patient |to |demonstrate |how |to |measure |and |administer |
insulin
A |patient |reports |that |a |medication |prescribed |for |recurrent |migraine |headaches |is |not |working. |
Which |action |is |the |prescriber's |priority |when |addressing |the |patient's |concern? |- |VERIFIED |ANSWER-
Ask |the |patient |about |the |number |and |frequency |of |tablets |taken.
The |drug |manual |states |that |older |adult |patients |are |at |increased |risk |for |hepatotoxicity. |Which |
action |is |most |important |when |prescribing |this |medication |to |an |80-year-old |patient? |- |VERIFIED |
ANSWER-Obtaining |baseline |liver |function |studies
A |patient |with |bipolar |disorder |is |prescribed |daily |lithium. |Which |action |is |most |important |for |the |
provider |to |take |in |order |to |determine |if |the |therapeutic |level |is |maintained? |- |VERIFIED |ANSWER-
Order |periodic |laboratory |testing.
Which |factor |best |supports |an |increase |for |full |prescriptive |authority |for |both |advanced |practice |
registered |nurses |(APRNs) |and |physician |assistants |(PAs)? |- |VERIFIED |ANSWER-More |patients |will |have
|access |to |health |care.
A |pediatric |patient |prescribed |ampicillin |for |streptococcal |pharyngitis |reports |new |onset |of |a |pruritic, |
dull |red, |maculopapular |rash |on |the |chest |and |neck. |Which |action |is |most |important |for |the |provider |
to |take |to |minimize |this |patient's |risk |for |injury? |- |VERIFIED |ANSWER-Discontinue |the |ampicillin.
, Which |prescriber |action |will |have |the |greatest |impact |on |the |patient's |commitment |to |adherence |to |
any |type |of |medication |therapy? |- |VERIFIED |ANSWER-Providing |medication |education |that |the |patient
|can |easily |understand
Which |patient |statement |suggests |to |the |provider |that |the |patient's |nonadherence |with |their |
medication |plan |is |related |to |dissatisfaction |with |the |therapy? |- |VERIFIED |ANSWER-"I've |been |taking |
this |medication |for |well |over |a |week |and |I |lost |only |a |half |a |pound."
How |can |the |prescriber's |regular |collaboration |with |a |pharmacist |improve |positive |outcomes |for |
patients? |- |VERIFIED |ANSWER-Pharmacists |have |additional |information |on |drug |interactions. |The |
pharmacist |can |suggest |adequate |medication |dosing. |Pharmacists |have |firsthand |knowledge |of |the |
facility |formulary.
Which |statements |made |by |the |prescriber |demonstrate |an |understanding |of |effective |medication |
education? |- |VERIFIED |ANSWER-"This |medication |needs |to |be |stored |in |the |refrigerator. |"Take |3 |
tablets |daily: |1 |with |breakfast, |1 |with |lunch, |and |one |with |dinner." |"You |need |to |take |the |medication |
as |we |discussed |until |all |the |tablets |are |gone." |"Call |the |office |immediately |if |you |begin |experiencing |
any |itching, |headache, |or |difficulty |breathing."
The |patient |who |has |been |prescribed |lithium |for |a |diagnosis |of |bipolar |disorder |asks |why |blood |tests |
are |required |on |a |regular |basis. |Which |provider |responses |demonstrate |an |understanding |of |why |the |
patient |requires |a |variety |of |laboratory |tests? |- |VERIFIED |ANSWER-"We |need |to |monitor |how |your |
thyroid |is |functioning." |"We |need |to |monitor |kidney |function |while |you |are |on |this |drug. |This |
medication |can |cause |you |to |lose |sodium, |so |we |need |to |measure |sodium |levels."
When |prescribing |lovastatin, |what |will |a |provider |advise |to |decrease |the |risk |of |developing |muscle |
toxicity? |- |VERIFIED |ANSWER-Substitute |grapefruit |juice |with |orange |juice
When |prescribing |drugs |with |a |narrow |therapeutic |index, |what |intervention |does |the |provider |take |to
|decrease |risk |to |the |patient? |- |VERIFIED |ANSWER-Monitor |the |patient's |plasma |drug |levels |at |regular |
intervals.
A |patient |reports |that |a |medication |no |longer |effectively |alleviates |symptoms. |What |process |informs |
the |provider's |response |to |the |patient's |concerns? |- |VERIFIED |ANSWER-Desensitization |of |receptor |
sites |results |from |continual |exposure |to |the |drug.
A |patient |reports |that |Brand |X |tablets |work |faster |than |Brand |Y |tablets |of |the |same |amount |of |the |
same |drug. |Which |statement |informs |the |prescriber's |response |when |explaining |this |phenomenon |to |
the |patient? |- |VERIFIED |ANSWER-Inactive |ingredients |used |in |composition |can |result |in |differing |rates |
of |dissolution, |which |can |alter |the |drug's |onset |of |action.
A |patient |receiving |intravenous |gentamicin |has |a |toxic |serum |drug |level. |The |prescriber |confirms |that |
the |dosing |is |correct. |Which |possible |cause |of |this |situation |will |the |provider |explore? |- |VERIFIED |
ANSWER-Whether |patient |is |taking |a |medication |that |binds |to |serum |albumin.
A |patient |takes |a |drug |that |is |metabolized |by |CYP3A4 |isoenzymes. |If |a |CYP3A4 |inducing |drug |is |
prescribed, |what |drug |adjustment |may |be |necessary |to |maintain |a |therapeutic |level |of |CYP3A4 |
substrate? |- |VERIFIED |ANSWER-Increase |dosage |of |the |CYP3A4 |substrate
